Stock listing

ANU Stock Price, News, Filings & Events — Xortx Therapeutics, Inc.

Selected listing: ANU · TRADEGATE · EUR · DE

Xortx Therapeutics, Inc. is listed on ANU:TRADEGATE. The company focuses on developing therapies for kidney diseases, with a particular emphasis on conditions related to high uric acid levels. Recent news highlights their ongoing clinical trials and research initiatives aimed at advancing their treatment options. Investors can find relevant filings and updates on upcoming events that may impact the company's market position.

ANU:TRADEGATEEURDEUpdated July 24, 2026
Xortx Therapeutics, Inc. logo
Ticker
ANU:TRADEGATE
Asset type
Stock
Market cap
$3.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Xortx Therapeutics, Inc. ANU:TRADEGATE stock context

Xortx Therapeutics, Inc. is listed on ANU:TRADEGATE. The company focuses on developing therapies for kidney diseases, with a particular emphasis on conditions related to high uric acid levels. Recent news highlights their ongoing clinical trials and research initiatives aimed at advancing their treatment options. Investors can find relevant filings and updates on upcoming events that may impact the company's market position.

Research Xortx Therapeutics, Inc.

Alternate listings